MAXCYTE, INC. Operating Income Loss

Quick Answer

MAXCYTE, INC. reported Operating Income Loss of -$51.90 million for the year ending 2025.

  • MAXCYTE, INC. showed a decrease of -1.4% in Operating Income Loss from 2024 to 2025.
  • This data is from MAXCYTE, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), MAXCYTE, INC.'s Operating Income Loss has declined by 317.9%.
  • Historical annual values: Fiscal year 2025: -$51.90 million | Fiscal year 2024: -$51.20 million | Fiscal year 2023: -$48.30 million | Fiscal year 2022: -$27.36 million | Fiscal year 2021: -$18.19 million | Fiscal year 2020: -$11.06 million | Fiscal year 2019: -$12.42 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: